Answers are grounded in this paper and cite their sources.
Thymidine Kinase 1 (TK1) is a cell cycle-regulated enzyme with peak expression during DNA synthesis (S phase) and is elevated in cancer patients, showing prognostic and predictive value in breast cancer. As CDK4/6 inhibitors block G1/S transition, serum TK1 is a promising marker for their anti-tumor effect.
No takes yet. Share an insight, caveat, or question.
Houdt et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: